Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9577 |
HCV-IN-31
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
HCV-IN-31 是一种HCV 抑制剂,EC50/EC95值为15.7 μM。 | |||
T15573 |
Inarigivir soproxil
SB9200 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Inarigivir soproxil (SB9200) 是一种先天免疫激动剂。 它还显示出针对耐药丙型肝炎病毒 (HCV) 变体的有效抗病毒活性。在基因型 1 HCV 复制子系统细胞中, HCV 1a/1b 的 EC50 为 2.2 和 1.0 μM。 | |||
T6229 |
Daclatasvir
Daklinza,达卡他韦,EBP 883,达拉他韦,BMS-790052 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Daclatasvir (EBP 883) 是一种高度选择性的 HCV NS5A 抑制剂,EC50 为 9-50 pM,适用于细胞培养中的多种 HCV 复制子基因型和 JFH-1 基因型 2a 感染性病毒。 | |||
T1786 |
Daclatasvir dihydrochloride
BMS-790052 dihydrochloride,盐酸达拉他韦 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) 是有机阴离子转运多肽 1B(OATP1B) 和 OATP1B3抑制剂,IC50分别为 1.5 µM 和 3.27 µM。它也具有口服活性的 HCV NS5A 蛋白抑制剂,多种 HCV 复制子基因型的 EC50范围为 9-146 pM。 | |||
T22142 |
RO8191
RO4948191,CDM-3008 |
HCV Protease; HBV; JAK; IFNAR; STAT | Angiogenesis; Chromatin/Epigenetic; Immunology/Inflammation; JAK/STAT signaling; Microbiology/Virology; Proteases/Proteasome; Stem Cells |
RO8191 (CDM-3008) 是干扰素 (IFN) 受体激动剂。它直接与 IFNα/β 受体 2 结合,激活 IFN 刺激的基因表达和 JAK/STAT 磷酸化。它通过具有干扰素样活性发挥 cccDNA 调节剂作用,并具有抗 HBV 活性。 | |||
TQ0162 |
R-1479
4'-Azidocytidine |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
R-1479 (4'-Azidocytidine) 是一种 RdRp 抑制剂,对于 HCV 亚基因组复制子系统中的 HCV RNA 复制,IC50 值为 1.28 μM。 | |||
T16088 |
MK-0608
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
MK-0608 是一种可口服的体外 HCV 复制抑制剂。在亚基因组复制子测定中,EC50值为 0.3 μM,EC90值为 1.3 μM。 | |||
T9249 |
ITMN4077
|
Antiviral | Immunology/Inflammation |
ITMN4077 对感染人类 HuH7 细胞的丙型肝炎病毒具有抗病毒活性,评估为抑制 HCV 亚基因组复制子复制,EC50 为 2.131μM。 | |||
T7215 |
NM107
NM-107,2'-C-甲基胞嘧啶核苷,2'-C-Methylcytidine |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
NM107 (2'-C-Methylcytidine) 是一种具有广谱抗病毒活性的核糖核苷,是丙型肝炎病毒 NS5B 聚合酶的核苷抑制剂,在野生型复制子细胞中的 EC50 为 1.85 μM。 | |||
T4988 |
Boceprevir
SCH 503034,EBP 520,波普瑞韦 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Boceprevir (SCH 503034) 是一种口服有效的选择性 HCV NS3 蛋白酶抑制剂。在酶试验中的 Ki 为 14 nM,在基于细胞的复制子试验中 EC90 为 350 nM。它也是 SARS-CoV-2 3CLpro 抑制剂。 | |||
T3334 |
Velpatasvir
GS-5816,维帕他韦 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Velpatasvir (GS-5816) 是一种的 HCV NS5A 抑制剂。它也是 SARS-CoV 3CLpro 的抑制剂,IC50为 2.16 μM。 | |||
T6729 |
Lomibuvir
VX-222,VCH-222 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Lomibuvir (VCH-222) (VX-222) 是丙型肝炎病毒 NS5B 聚合酶的一种非核苷变构抑制剂,Kd 值为 17 nM,已证明具有临床疗效。Lomibuvir 抑制 1b/Con1 型 HCV 亚基因组复制子,EC50为 5.2 nM。Lomibuvir 优先抑制延长的 RNA 合成,而非从头合成的 RNA。 | |||
T60531 |
2'-C-Methyladenosine
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
2'-C-Methyladenosine 是丙型肝炎病毒(HCV)复制的抑制剂,分离自肾棒状杆菌。2'-C-Methyladenosine 抑制 HCV 复制子和 NS5B 催化的 RNA 合成,IC50值分别为 0.3 μM 和 1.9 μM。2'-C-Methyladenosine 还对Leishmania guyanensis (Lgy)和Leishmania braziliensis中的 LRV1有抑制作用。 | |||
T6200 |
Ledipasvir
GS-5885,雷迪帕韦 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Ledipasvir (GS-5885) 是一种丙型肝炎病毒 NS5A 抑制剂。它也是 P-糖蛋白抑制剂和乳腺癌抗性蛋白抑制剂。 | |||
T38237 |
2′-O-Methylcytidine
|
Nucleoside Antimetabolite/Analog; HCV Protease | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology; Proteases/Proteasome |
2'-O-Methylcytidine 是 2'-代核苷,可抑制 HCV 复制。 它在体外抑制 NS5B 催化的 RNA 合成,其抑制方式是与底物核苷三磷酸竞争。 | |||
T64202 | HCV-IN-40 | ||
HCV-IN-39 (Compound 18a) 是一种有效的、口服具有活力的 hepatitis C virus (HCV) 核苷抑制剂,能够作用于 GT1a 复制子 (EC50: 0.259 μM)、GT1b 复制子 (EC50: 0.434 μM) 和 GT1b CES1 复制子 (EC50: 0.069 μM)。 | |||
T70274 | FR171456 | ||
FR171456 is a natural specific inhibitor of mammalian nsdhl and yeast erg26p, inhibiting an artificial hepatitis c viral replicon, and showung broad antifungal activity | |||
T11832 |
Ledipasvir D-tartrate
GS-5885 D-tartrate,雷迪帕韦 D-酒石酸 |
Others | Others |
Ledipasvir D-tartrate with EC50 values of 34 pM against GT1a and 4 pM against GT1b replicon. is an inhibitor of the hepatitis C virus NS5A. | |||
T15631 | JTK-853 | Others | Others |
JTK-853 is a novel, non-nucleoside inhibitor of Hepatitis C Virus (HCV) polymerase. It also displays effective antiviral activity in HCV replicon cells (EC50s: 0.38 and 0.035 µM in genotype 1a H77 and 1b Con1 strains, respectively). | |||
T27125 |
DBPR-110
MB110,MB 110,MB-110 |
||
DBPR-110 is a nonstructural protein 5A (NS5A) inhibitor. DBPR-110 reduced the reporter expression of the HCV1b replicon with a EC(50) and a selective index value of 3.9 ± 0.9 pM and >12,800,000, respectively. DBPR-110 reduced HCV2a replicon activity with | |||
T75241 |
Ledipasvir hydrochloride
GS-5885 hydrochloride |
||
Ledipasvir (GS-5885) hydrochloride 是抗HCV NS5A 的高效抑制剂,对GT1a 和 GT1b 复制子抑制作用显著,其EC50值仅为34 pM 和 4 pM。此外,Ledipasvir hydrochloride 还能抑制 SARS-CoV 3CLpro, IC50 为1.62 μM。 | |||
T12959 |
Sofosbuvir impurity D
|
Others | Others |
Sofosbuvir impurity D is the less active impurity of Sofosbuvir. Sofosbuvir is an active HCV RNA replication inhibitor in the HCV replicon assay,with potent anti-hepatitis C virus (HCV) activity. | |||
T12960 |
Sofosbuvir impurity E
|
Others | Others |
Sofosbuvir impurity E is the less active impurity of Sofosbuvir. Sofosbuvir is an active HCV RNA replication inhibitor in the HCV replicon assay,with potent anti-hepatitis C virus (HCV) activity. | |||
T16715 |
Furaprofen
呋喃洛芬,R803 |
Others | Others |
Furaprofen is substantially more potent against genotype 1a and 1b replicons (EC50, ~30 nM) than against the genotype 2a replicon (EC50:1000 nM). Furaprofen is an effective HCV replication inhibitor. | |||
T12954 |
Sofosbuvir 13CD3
GS-7977 13CD3,PSI-7977 13CD3 |
Others | Others |
Sofosbuvir 13CD3 is the deuterium labeled Sofosbuvir. Sofosbuvir is an active HCV RNA replication inhibitor in the HCV replicon assay, with potent anti-hepatitis C virus (HCV) activity. | |||
T63593 |
Dasabuvir sodium
|
||
Dasabuvir (ABT-333) sodium 是非核苷丙型肝炎病毒 (HCV) 聚合酶抑制剂。Dasabuvir sodium 对 HCV NS5B 基因编码的 RNA 依赖性 RNA 聚合酶 (RNA polymerase) 表现出抑制作用。Dasabuvir sodium 能够抑制基因型 1a (菌株 H77) 复制子 (EC50: 7.7 nM) 和 1b (菌株 Con1) 复制子 (EC50: 1.8 nM)。 | |||
T12958 | Sofosbuvir impurity C | Others | Others |
Sofosbuvir impurity C is the less active impurity of Sofosbuvir. Sofosbuvir is an active HCV RNA replication inhibitor in the HCV replicon assay,with potent anti-hepatitis C virus (HCV) activity. | |||
T12955 |
Sofosbuvir D6
PSI-7977 D6,GS-7977 D6 |
Others | Others |
Sofosbuvir D6 is the deuterium labeled Sofosbuvir. Sofosbuvir is an active inhibitor of HCV RNA replication in the HCV replicon assay, demonstrates potent anti-hepatitis C virus (HCV) activity. | |||
T71085 |
BMS-824
|
||
BMS-824 is a potent NS5A inhibitor. The 50% inhibition of HCV replicon replication for BMS-824 was approximately 5 nM, with a therapeutic index of >10,000. BMS-824 showed good specificity for HCV, as it was not active against several other RNA and DNA viruses. | |||
T12957 |
Sofosbuvir impurity B
|
Others | Others |
Sofosbuvir impurity B is the less active impurity of Sofosbuvir. Sofosbuvir is an active HCV RNA replication inhibitor in the HCV replicon assay, with potent anti-hepatitis C virus (HCV) activity. | |||
T74070 | NHC-triphosphate tetrasodium | ||
NHC-triphosphate tetrasodium 是 NHC 的活性胞内磷酸盐代谢物 (intracellular metabolite),以三磷酸盐的形式存在。NHC-triphosphate tetrasodium 是病毒聚合酶 (viral polymerase) 的弱底物替代物,会被并入HCV 复制子 RNA 中。 | |||
T29176 |
YKL-04-085
YKL 04085,YKL04-085,YKL 04-085,YKL-04085 |
||
YKL-04-085 is a potent inhibitor of viral translation. YKL-04-085 has cellular antiviral activity at 35-fold lower concentrations relative to inhibition of host-cell proliferation. YKL-04-085 demonstrated good inhibition of translation of the DENV2(GVD) r | |||
T60440 | Antiviral agent 17 | ||
Antiviral agent 17 (Compound 4) 是一种抗感染剂,在人类复制子试验中显著保留其抗病毒作用,EC50值为0.015 μM。Antiviral agent 17 对小鼠诺如病毒(MNV)表现出良好的抗病毒活性。Antiviral agent 17 在研究传染性和恶性疾病方面具有潜力。 | |||
T36881 | NHC-diphosphate triammonium | ||
NHC-triphosphate triammonium is an active phosphorylated intracellular metabolite of β-d-N4-Hydroxycytidine (NHC) as a triphosphate form[1]. NHC-triphosphate triammonium is a weak alternative substrate for the viral polymerase and can be incorporated into HCV replicon RNA[1][2]. In an intracellular metabolism assay, HCV replicon cells are treated with 10 μM 3H-labeled NHC, and intracellular nucleotide levels are determined after 1, 2 and 8 hours incubations. NHC is rapidly convered into the mono... | |||
T73814 |
cis-Lomibuvir
|
||
cis-Lomibuvir (cis-VX-222) 是 Lomibuvir 的顺式异构体。Lomibuvir (VX-222) 是一种选择性的非核苷聚合酶抑制剂,靶向丙型肝炎病毒 NS5B 聚合酶 (RdRp) 的拇指口袋 2,Kd 为 17 nM。Lomibuvir 抑制 1b/Con1 型 HCV 亚基因组复制子,EC50为 5.2 nM。Lomibuvir 优先抑制延长的 RNA 合成,而非从头合成的 RNA。 | |||
T16274 |
Narlaprevir
SCH 900518,那拉匹韦 |
Others | Others |
Narlaprevir is an effective, selective, and orally bioavailable NS3 protease inhibitor(Ki=6 nM; EC90=40 nM). |